| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Sirolimus vs paclitaxel-coated balloons in in-stent coronary restenosis: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Debvarsha Mandal, Thomas Viji Pulickal, Dhritika Ahlawat, Wasiullah Haqbeen, Izma Kashif, Haroon Alamy, Pramoda Prattipati, Padmavathi Jaladi, Paula Kabiaru, Anjali Avula, Sandeep Kshetri, Irum Raza, Samir Shamieh and Rejina Chhetri |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rejina Chhetri, MD, Department of Cardiology, Nepalgunj Medical College, Nepalgunj Medical College Chisapani Banke Baijanath 1 Chisapani, Kohal 21900, Nepal. rejinachhetri01@gmail.com |
| Key Words |
Sirolimus coated balloon; Paclitaxel coated balloon; In-stent restenosis; Coronary interventions; Cardiovascular outcomes |
| Core Tip |
This meta-analysis systematically compares sirolimus-coated balloons (SCBs) and paclitaxel-coated balloons (PCBs) for treating coronary in-stent restenosis (ISR). Synthesizing data from randomized controlled trials and observational studies, the findings demonstrate no significant differences between SCBs and PCBs in efficacy or safety outcomes, including target lesion revascularization and major adverse cardiovascular events. These results support flexible clinical use of either DCB type for ISR, while highlighting the need for further research into long-term outcomes and high-risk patient subgroups. |
| Publish Date |
2026-02-10 10:35 |
| Citation |
Mandal D, Pulickal TV, Ahlawat D, Haqbeen W, Kashif I, Alamy H, Prattipati P, Jaladi P, Kabiaru P, Avula A, Kshetri S, Raza I, Shamieh S, Chhetri R. Sirolimus vs paclitaxel-coated balloons in in-stent coronary restenosis: A meta-analysis. World J Methodol 2026; 16(1): 111566 |
| URL |
https://www.wjgnet.com/2222-0682/full/v16/i1/111566.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v16.i1.111566 |
